References analysis of the Wikipedia article "Fator D" in the Portuguese version

doi.org

dx.doi.org

Narayana SV, Carson M, el-Kabbani O, Kilpatrick JM, Moore D, Chen X, Bugg CE, Volanakis JE, DeLucas LJ (1994). «Structure of human factor D. A complement system protein at 2.0 A resolution». Journal of Molecular Biology. 235 (2): 695–708. PMID 8289289. doi:10.1006/jmbi.1994.1021

Ronti T, Lupattelli G, Mannarino E (2006). «The endocrine function of adipose tissue: an update». Clinical Endocrinology. 64: 355–65. PMID 16584505. doi:10.1111/j.1365-2265.2006.02474.x

Flier JS, Cook KS, Usher P, Spiegelman BM (1987). «Severely impaired adipsin expression in genetic and acquired obesity». Science. 237: 405–8. Bibcode:1987Sci...237..405F. PMID 3299706. doi:10.1126/science.3299706

Volanakis JE, Narayana SV (1996). «Complement factor D, a novel serine protease». Protein Science. 5: 553–64. PMC 2143395

. PMID 8845746. doi:10.1002/pro.5560050401

Lesavre, PH; Müller-Eberhard, HJ (1 de dezembro de 1978). «Mechanism of action of factor D of the alternative complement pathway.». The Journal of Experimental Medicine. 148: 1498–509. PMC 2185104

. PMID 82604. doi:10.1084/jem.148.6.1498

Jing, H; Babu, YS; Moore, D; Kilpatrick, JM; Liu, XY; Volanakis, JE; Narayana, SV (9 de outubro de 1998). «Structures of native and complexed complement factor D: implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity.». Journal of Molecular Biology. 282: 1061–81. PMID 9753554. doi:10.1006/jmbi.1998.2089

Jing, H; Macon, KJ; Moore, D; DeLucas, LJ; Volanakis, JE; Narayana, SV (15 de fevereiro de 1999). «Structural basis of profactor D activation: from a highly flexible zymogen to a novel self-inhibited serine protease, complement factor D.». The EMBO Journal. 18: 804–14. PMC 1171173

. PMID 10022823. doi:10.1093/emboj/18.4.804

Karki, RG; Powers, J; Mainolfi, N; Anderson, K; Belanger, DB; Liu, D; Ji, N; Jendza, K; Gelin, CF (9 de maio de 2019). «Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway.». Journal of Medicinal Chemistry. 62: 4656–4668. PMID 30995036. doi:10.1021/acs.jmedchem.9b00271

Forneris, F; Ricklin, D; Wu, J; Tzekou, A; Wallace, RS; Lambris, JD; Gros, P (24 de dezembro de 2010). «Structures of C3b in complex with factors B and D give insight into complement convertase formation.». Science. 330: 1816–20. Bibcode:2010Sci...330.1816F. PMC 3087196

. PMID 21205667. doi:10.1126/science.1195821

Vulpetti, A; Randl, S; Rüdisser, S; Ostermann, N; Erbel, P; Mac Sweeney, A; Zoller, T; Salem, B; Gerhartz, B (9 de março de 2017). «Structure-Based Library Design and Fragment Screening for the Identification of Reversible Complement Factor D Protease Inhibitors.». Journal of Medicinal Chemistry. 60: 1946–1958. PMID 28157311. doi:10.1021/acs.jmedchem.6b01684

Maibaum, J; Liao, SM; Vulpetti, A; Ostermann, N; Randl, S; Rüdisser, S; Lorthiois, E; Erbel, P; Kinzel, B (dezembro de 2016). «Small-molecule factor D inhibitors targeting the alternative complement pathway.». Nature Chemical Biology. 12: 1105–1110. PMID 27775713. doi:10.1038/nchembio.2208

Vulpetti, A; Ostermann, N; Randl, S; Yoon, T; Mac Sweeney, A; Cumin, F; Lorthiois, E; Rüdisser, S; Erbel, P (10 de maio de 2018). «Discovery and Design of First Benzylamine-Based Ligands Binding to an Unlocked Conformation of the Complement Factor D.». ACS Medicinal Chemistry Letters. 9: 490–495. PMC 5949727

. PMID 29795765. doi:10.1021/acsmedchemlett.8b00104

Hayashi, M; Machida, T; Ishida, Y; Ogata, Y; Omori, T; Takasumi, M; Endo, Y; Suzuki, T; Sekimata, M (15 de setembro de 2019). «Cutting Edge: Role of MASP-3 in the Physiological Activation of Factor D of the Alternative Complement Pathway.». Journal of Immunology. 203: 1411–1416. PMID 31399515. doi:10.4049/jimmunol.1900605

Lorthiois, E; Anderson, K; Vulpetti, A; Rogel, O; Cumin, F; Ostermann, N; Steinbacher, S; Mac Sweeney, A; Delgado, O (13 de julho de 2017). «Discovery of Highly Potent and Selective Small-Molecule Reversible Factor D Inhibitors Demonstrating Alternative Complement Pathway Inhibition in Vivo.». Journal of Medicinal Chemistry. 60: 5717–5735. PMID 28621538. doi:10.1021/acs.jmedchem.7b00425

Dobó, J; Kocsis, A; Gál, P (2018). «Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases.». Frontiers in Immunology. 9. 1851 páginas. PMC 6092519

. PMID 30135690. doi:10.3389/fimmu.2018.01851

Volanakis, JE; Barnum, SR; Giddens, M; Galla, JH (14 de fevereiro de 1985). «Renal filtration and catabolism of complement protein D.». The New England Journal of Medicine. 312: 395–9. PMID 3844050. doi:10.1056/NEJM198502143120702

Pascual, M; Steiger, G; Estreicher, J; Macon, K; Volanakis, JE; Schifferli, JA (outubro de 1988). «Metabolism of complement factor D in renal failure.». Kidney International. 34: 529–36. PMID 3199673. doi:10.1038/ki.1988.214

Biesma, DH; Hannema, AJ; van Velzen-Blad, H; Mulder, L; van Zwieten, R; Kluijt, I; Roos, D (julho de 2001). «A family with complement factor D deficiency.». The Journal of Clinical Investigation. 108: 233–40. PMC 203023

. PMID 11457876. doi:10.1172/JCI12023

Hiemstra, PS; Langeler, E; Compier, B; Keepers, Y; Leijh, PC; van den Barselaar, MT; Overbosch, D; Daha, MR (dezembro de 1989). «Complete and partial deficiencies of complement factor D in a Dutch family.». The Journal of Clinical Investigation. 84: 1957–61. PMC 304077

. PMID 2687330. doi:10.1172/JCI114384

Yuan, X; Gavriilaki, E; Thanassi, JA; Yang, G; Baines, AC; Podos, SD; Huang, Y; Huang, M; Brodsky, RA (março de 2017). «Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.». Haematologica. 102: 466–475. PMC 5394948

. PMID 27810992. doi:10.3324/haematol.2016.153312

nih.gov

ncbi.nlm.nih.gov

Ronti T, Lupattelli G, Mannarino E (2006). «The endocrine function of adipose tissue: an update». Clinical Endocrinology. 64: 355–65. PMID 16584505. doi:10.1111/j.1365-2265.2006.02474.x